Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; providing for the distribution of revenue attributable to the addition modification; etc.
1 bill selected
Basic Information
- Status
- Chaptered
- Session
- 2026 Regular Session
- Type
- Unknown
- Cross-filed
- False
Links
- State Link
- View on State Website
- LegiScan URL
- View on LegiScan
Sponsors
Lewis Young